仙骨神経刺激装置 - 世界市場の考察、競合情勢、市場予測（2030年）

世界の仙骨神経刺激装置の市場規模は、2023年に10億6,405万米ドルに達し、2024年～2030年の予測期間にCAGRで11.66％の成長が見込まれます。仙骨神経刺激装置の需要は主に、尿閉、切迫性頻尿、便失禁などの増加によって後押しされています。さらに、革新的な先進技術の採用の高まり、低侵襲治療アプローチに対する需要の高まり、製品の発売と承認の増加などが、2024年～2030年の予測期間の仙骨神経刺激装置市場の全体的な成長に寄与しています。

仙骨神経刺激装置の市場力学

仙骨神経刺激装置市場は、過活動膀胱（OAB）、尿失禁、便失禁、前立腺がんなどの症例の増加により、製品需要が活発に伸びています。これらの疾患は、尿失禁や便失禁により人の通常のライフスタイルを妨げる可能性があります。したがって、仙骨神経刺激装置は、膀胱や腸のコントロールの問題を大幅に軽減または解消することができます。例えば、American Society of Clinical Oncologyによると、2022年に米国で26万8,490人近くの男性が前立腺がんと診断されたと推定されています。同じ資料によると、2020年に世界中で約141万4,259人の男性が前立腺がんと診断されたと推定されています。前立腺がんは、男性でもっとも一般的ながんです。前立腺がんは、尿閉や切迫性尿失禁などの合併症を引き起こし、人を不快にします。尿閉や切迫性尿失禁は、排尿の切迫を感知して脳に信号を送る仙骨神経刺激装置の助けを借りてコントロールすることができます。したがって、前立腺がんの症例が増加していることから、市場における仙骨神経刺激装置の需要が増加する可能性があります。

さらに、排尿機能障害、尿失禁、便失禁などの疾患は老年人口に非常に多いです。加齢は筋肉の緩みに影響する心理社会的要因の有病率の増加と関連しているため、60歳以上の人々は前述の疾患を発症するリスクが高いです。世界保健機関（WHO）（2022）によると、2030年までに世界の6人に1人が60歳以上になると予測されています。この時、60歳以上の人口に占める割合は、世界全体で2020年の10億人から2030年までに14億人に増加します。さらに2050年までに、世界の60歳以上の人口は倍増し、21億人近くになります。同統計によれば、80歳以上の人口は2020年～2050年に3倍に増え、世界で4億2,600万人に達すると予測されています。したがって、増加している老年人口は尿失禁や膀胱機能障害のリスクが高く、それらは仙骨神経刺激装置の使用によってコントロールできます。仙骨神経刺激装置は膀胱を感知し、時間通りに排尿するよう脳に信号を送ることができるためです。したがって、老年人口の増加は仙骨神経刺激装置の需要を増加させ、それによって市場全体の成長を促進する可能性があります。

したがって、上記の要因が2024年～2030年の予測期間の仙骨神経刺激装置市場の成長に寄与しています。

しかし、植込み型装置に関連する合併症などが、仙骨神経刺激装置市場の成長を抑制する可能性があります。

仙骨神経刺激装置市場は、COVID-19パンデミック期間にマイナスの影響を受けました。パンデミックの発生は、外来受診のキャンセルや、緊急性のない病院受診の中止、外科手術のキャンセルにつながりました。さらに、COVID-19患者の治療が優先されたため、多くの選択的手術が延期されました。さらに、サプライチェーンや原材料などの制限により、装置の製造がストップし、市場での装置不足につながっています。しかし、COVID-19のワクチン開発が景気回復のきっかけとなっています。また、ロックダウン規制が緩和され、経済情勢が正常化したことで、さまざまな慢性疾患の治療に向けた外来受診や手術といった通常の医療サービスが再開されるようになり、仙骨神経刺激装置市場における製品需要が軌道に乗っています。

当レポートでは、世界の仙骨神経刺激装置市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 仙骨神経刺激装置市場レポートのイントロダクション

第2章 仙骨神経刺激装置市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 仙骨神経刺激装置市場の主な要因の分析

• 仙骨神経刺激装置市場の促進要因
• 仙骨神経刺激装置市場の抑制要因と課題
• 仙骨神経刺激装置市場の機会

第5章 仙骨神経刺激装置市場のポーターのファイブフォース分析

第6章 仙骨神経刺激装置市場に対するCOVID-19の影響分析

第7章 仙骨神経刺激装置市場のレイアウト

• 製品別
  • 植込み型神経刺激装置
  • 体外式神経刺激装置
• 用途別
  • 過活動膀胱
  • 尿失禁、腸切迫性失禁
  • 非閉塞性尿閉
  • 慢性便失禁
  • その他
• エンドユーザー別
  • 病院
  • 外来手術センター
• 地域
  • 北米の仙骨神経刺激装置の市場規模（2021年～2030年）
  • 欧州の仙骨神経刺激装置の市場規模（2021年～2030年）
  • アジア太平洋の仙骨神経刺激装置の市場規模（2021年～2030年）
  • その他の地域の仙骨神経刺激装置の市場規模（2021年～2030年）

第8章 仙骨神経刺激装置市場の企業と製品のプロファイル

• Medtronic
• Axonics, Inc.
• Boston Scientific Corporation
• .NeuroPace, Inc.
• Laborie.
• Biegler GmbH
• Finetech Medical

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis
• Table 3: Sacral Nerve Stimulator Device Market in Global (2021-2030)
• Table 4: Sacral Nerve Stimulator Device Market in Global by Product (2021-2030)
• Table 5: Sacral Nerve Stimulator Device Market in Global by Application (2021-2030)
• Table 6: Sacral Nerve Stimulator Device Market in Global by End-User (2021-2030)
• Table 7: Sacral Nerve Stimulator Device Market in Global by Geography (2021-2030)
• Table 8: Sacral Nerve Stimulator Device Market in North America (2021-2030)
• Table 9: Sacral Nerve Stimulator Device Market in North America by Country (2021-2030)
• Table 10: Sacral Nerve Stimulator Device Market in the US (2021-2030)
• Table 11: Sacral Nerve Stimulator Device Market in Canada (2021-2030)
• Table 12: Sacral Nerve Stimulator Device Market in Mexico (2021-2030)
• Table 13: Sacral Nerve Stimulator Device Market in Europe (2021-2030)
• Table 14: Sacral Nerve Stimulator Device Market in Europe by Country (2021-2030)
• Table 15: Sacral Nerve Stimulator Device Market in France (2021-2030)
• Table 16: Sacral Nerve Stimulator Device Market in Germany (2021-2030)
• Table 17: Sacral Nerve Stimulator Device Market in the United Kingdom (2021-2030)
• Table 18: Sacral Nerve Stimulator Device Market in Italy (2021-2030)
• Table 19: Sacral Nerve Stimulator Device Market in Spain (2021-2030)
• Table 20: Sacral Nerve Stimulator Device Market in the Rest of Europe (2021-2030)
• Table 21: Sacral Nerve Stimulator Device Market in Asia-Pacific (2021-2030)
• Table 22: Sacral Nerve Stimulator Device Market in Asia-Pacific by Country (2021-2030)
• Table 23: Sacral Nerve Stimulator Device Market in China (2021-2030)
• Table 24: Sacral Nerve Stimulator Device Market in Japan (2021-2030)
• Table 25: Sacral Nerve Stimulator Device Market in India (2021-2030)
• Table 26: Sacral Nerve Stimulator Device Market in Australia (2021-2030)
• Table 27: Sacral Nerve Stimulator Device Market in South Korea (2021-2030)
• Table 28: Sacral Nerve Stimulator Device Market in Rest of Asia-Pacific (2021-2030)
• Table 29: Sacral Nerve Stimulator Device Market in the Rest of the World (2021-2030)
• Table 30: Sacral Nerve Stimulator Device Market in RoW by Region (2021-2030)
• Table 31: Sacral Nerve Stimulator Device Market in the Middle East (2021-2030)
• Table 32: Sacral Nerve Stimulator Device Market in Africa (2021-2030)
• Table 33: Sacral Nerve Stimulator Device Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis
• Figure 3: Sacral Nerve Stimulator Device Market in Global (2021-2030)
• Figure 4: Sacral Nerve Stimulator Device Market in Global by Product (2021-2030)
• Figure 5: Sacral Nerve Stimulator Device Market in Global by Application (2021-2030)
• Figure 6: Sacral Nerve Stimulator Device Market in Global by End-User (2021-2030)
• Figure 7: Sacral Nerve Stimulator Device Market in Global by Geography (2021-2030)
• Figure 8: Sacral Nerve Stimulator Device Market in North America (2021-2030)
• Figure 9: Sacral Nerve Stimulator Device Market in North America by Country (2021-2030)
• Figure 10: Sacral Nerve Stimulator Device Market in the US (2021-2030)
• Figure 11: Sacral Nerve Stimulator Device Market in Canada (2021-2030)
• Figure 12: Sacral Nerve Stimulator Device Market in Mexico (2021-2030)
• Figure 13: Sacral Nerve Stimulator Device Market in Europe (2021-2030)
• Figure 14: Sacral Nerve Stimulator Device Market in Europe by Country (2021-2030)
• Figure 15: Sacral Nerve Stimulator Device Market in France (2021-2030)
• Figure 16: Sacral Nerve Stimulator Device Market in Germany (2021-2030)
• Figure 17: Sacral Nerve Stimulator Device Market in the United Kingdom (2021-2030)
• Figure 18: Sacral Nerve Stimulator Device Market in Italy (2021-2030)
• Figure 19: Sacral Nerve Stimulator Device Market in Spain (2021-2030)
• Figure 20: Sacral Nerve Stimulator Device Market in the Rest of Europe (2021-2030)
• Figure 21: Sacral Nerve Stimulator Device Market in Asia-Pacific (2021-2030)
• Figure 22: Sacral Nerve Stimulator Device Market in Asia-Pacific by Country (2021-2030)
• Figure 23: Sacral Nerve Stimulator Device Market in China (2021-2030)
• Figure 24: Sacral Nerve Stimulator Device Market in Japan (2021-2030)
• Figure 25: Sacral Nerve Stimulator Device Market in India (2021-2030)
• Figure 26: Sacral Nerve Stimulator Device Market in Australia (2021-2030)
• Figure 27: Sacral Nerve Stimulator Device Market in South Korea (2021-2030)
• Figure 28: Sacral Nerve Stimulator Device Market in Rest of Asia-Pacific (2021-2030)
• Figure 29: Sacral Nerve Stimulator Device Market in the Rest of the World (2021-2030)
• Figure 30: Sacral Nerve Stimulator Device Market in RoW by Region (2021-2030)
• Figure 31: Sacral Nerve Stimulator Device Market in the Middle East (2021-2030)
• Figure 32: Sacral Nerve Stimulator Device Market in Africa (2021-2030)
• Figure 33: Sacral Nerve Stimulator Device Market in South America (2021-2030)
• Figure 34: Market Drivers
• Figure 35: Market Barriers
• Figure 36: Marker Opportunities
• Figure 37: PORTER'S Five Force Analysis

Sacral Nerve Stimulator Devices Market By Product (Implantable Nerve Stimulator And External Nerve Stimulator), By Application (Overactive Bladder, Urinary Or Bowel Urge Incontinence, Chronic Fecal Incontinence, And Others), By End-User (Hospitals, Ambulatory Surgical Centers, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of overactive bladder and urge incontinence and the rising technological advancements

The global sacral nerve stimulator devices market was valued at USD 1,064.05 million in 2023, growing at a CAGR of 11.66% during the forecast period from 2024 to 2030. The demand for sacral nerve stimulator devices is primarily being boosted by the increasing figures for urinary retention, urgency frequency, fecal incontinence, and others. Further, the rising adoption of advanced and innovative technologies, the rising demand for minimally invasive treatment approaches, and the increasing product launches and approval among others are thereby contributing to the overall growth of the sacral nerve stimulator devices market during the forecast period from 2024-2030.

Sacral Nerve Stimulator Devices Market Dynamics:

The sacral nerve stimulator devices market is witnessing a positive growth in product demand due to the increasing cases of overactive bladder (OAB), urine & fecal incontinence, prostate cancer, and others. These diseases may disturb the normal lifestyle of a person owing to incontinence of urine and stool. Thus, a sacral nerve stimulator can greatly reduce or eliminate bladder and bowel control problems. For instance, according to American Society of Clinical Oncology 2022, it was estimated that in 2022 nearly 268,490 men in the United States were diagnosed with prostate cancer. As per the same source, it was estimated that approximately 1,414,259 men were diagnosed with prostate cancer worldwide in 2020. Prostate cancer is the most common cancer among men. Prostate cancer causes complications like urinary retention and urges incontinence which makes a person uncomfortable. Urinary retention or urge incontinence can be controlled with the help of a sacral nerve stimulator that senses the urgency of urination and send the signal to the brain. Thus, the increasing cases of prostate cancer may increase the demand for sacral nerve stimulators in the market.

Further, voiding dysfunction, urinary incontinence, fecal incontinence, and other diseases are very common in the older population. People more than 60 years are at a higher risk of developing the afore-said diseases as aging is associated with the increasing prevalence of psychosocial factors which affect the loosening of muscles. As per World Health Organization (WHO) 2022, it is predicted that by 2030, one in six people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion in 2030, worldwide. Moreover, by 2050, the world's population of people aged 60 years and older will double which is nearly 2.1 billion. The statistics provided by the same source stated that the number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million, globally. Thus, the increasing geriatric population will be at high risk of urinary incontinence and bladder dysfunction which can be controlled by using a sacral nerve stimulator as sacral nerve stimulator can sense the bladder and send a signal to the brain for urination on time. Thus, the increasing geriatric population may increase the demand for sacral nerve stimulators, thereby propelling the overall market growth.

Therefore, the above-mentioned factors are contributing to the growth of the sacral nerve stimulator devices market during the forecast period from 2024-2030.

However, complications related to implantable devices, and others may restrict the sacral nerve stimulator devices market growth.

The sacral nerve stimulator market was negatively impacted during the period of COVID- 19 pandemic. The outbreak of the pandemic led to the cancellation of outpatient visits, the suspension of non-emergency hospital visits, and the cancellation of surgical procedures. Moreover, many elective surgeries were postponed as treatment of patients suffering from coronavirus infection was on priority. Additionally, the restrictions on the supply chain, raw materials, and other resources halted the manufacturing of devices, leading to a shortage of devices in the market. However, the vaccine development of COVID-19 initiated the process of economic recovery. Also, the easing of lockdown restrictions and the return of normalcy in the economic landscape initiated the process of resumption of regular healthcare services such as outpatient visits and surgeries for the treatment of various chronic ailments, thereby bringing the demand for products on track in the sacral nerve stimulator market.

Sacral Nerve Stimulator Devices Market Segment Analysis:

Sacral nerve stimulator devices by Product (Implantable Nerve Stimulator and External Nerve Stimulator), Application (Overactive Bladder (OAB), Urinary or Bowel Urge Incontinence, Chronic Fecal Incontinence, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the sacral nerve stimulator devices market, the implantable nerve stimulator category is expected to amass significant revenue share in the year 2023. This can be ascribed to the advantages offered by the segment.

For instance, the advantages of implantable sacral nerve stimulators over other products include quicker signal response, less discomfort, minimal invasion, and shorter operating times.

The increasing prevalence of OAB, urine & fecal incontinence, and others may also increase the demand for implantable nerve stimulators.

OAB may affect relationships with friends and family. It can disrupt a person's sleep & sex life and can leave anyone tired and depressed. OAB can lead to urge incontinence, urinating frequent, nocturia, and others. An implantable nerve stimulator can be used to sense quicker urine urgency and can send a signal of the urgency to the brain which may aid in curing the symptoms of urinary incontinence. Thus, the increasing demand for sacral nerve stimulators for the treatment of OAB may lead to an increased demand for implantable nerve stimulator devices.

Furthermore, the increasing awareness regarding sacral nerve stimulators, product launches, and approvals are also a factor for the implantable sacral nerve stimulator market growth. For instance, in 2022, the Axonics F15 device was cleared by the FDA, allowing it to be implanted for upward of 15 years to block the abnormal nerve signals linked to overactive bladder and fecal incontinence.

Therefore, the advantages offered by implantable sacral nerve stimulators are predicted to contribute to the increasing demand for this product thereby driving the growth of the overall sacral nerve stimulator devices market during the forecast period.

North America is expected to dominate the overall Sacral Nerve Stimulator Devices Market:

Among all the regions, North America is estimated to account for the largest share of the sacral nerve stimulator devices market in the year 2023. Factors such as the growing prevalence of urine & fecal incontinence and the increasing cases of OAB are driving the North America sacral nerve stimulator devices market. Further, the increasing geriatric population, the high disposable income, the sophisticated healthcare infrastructure, the regulatory approval for new devices, and the high awareness about the devices also helped the market growth in this region.

Further, people who have urinary retention may have complications, including urinary tract infection (UTI), bladder damage, and kidney damage. According to the Urology Care Foundation 2020, UTIs are very common in the US. In premenopausal women, an annual estimated incidence of UTI is 0.5 - 0.7 per person reported in the US, yearly.

Further, various studies have stated that sacral neuromodulator (SNM) has a positive therapeutic effect on the lower urinary tract and has shown to be an effective treatment for UTI. The urinary tract infection may cause urge incontinence and these patients may require sacral nerve stimulators.

Moreover, the device can also be discontinued at any time without any permanent damage to the nerve. Thus, the increasing number of cases of UTI may increase the number of urinary incontinence cases, ultimately increasing the demand for sacral nerve stimulators, thereby increasing the overall market in the region.

Coupled with the factors mentioned above, strategic activities such as product launches and approvals, mergers, acquisitions, partnerships, and others also help in boosting regional product demand. For instance, in February 2022 Medtronic plc, a global leader in healthcare technology, received approval from the US Food and Drug Administration (FDA) for InterStim X(TM), the next generation of the InterStim(TM) portfolio's recharge-free neurostimulation device, which offers more than 10 years of battery life without the need to recharge, providing patients with more freedom and less maintenance. Thus, such strategic steps help to increase the demand for sacral nerve stimulator devices, thereby driving the North American sacral nerve stimulator devices market forward during the forecast period.

Sacral Nerve Stimulator Devices Market Key Players:

Some of the key market players operating in the sacral nerve stimulator devices market include Medtronic, Axonics, Inc., Boston Scientific Corporation, NeuroPace, Inc., Laborie, Biegler GmbH, Finetech Medical, and others.

Recent Developmental Activities in the Sacral Nerve Stimulator Devices Market:

In February 2023, the US FDA approved Axonics Inc's 4th-generation rechargeable neurostimulator for the treatment of fecal incontinence and overactive bladder.

In August 2021, in the US Finetech-Brindley, a bladder control system was launched as an active implantable medical device and is intended for restoration of bladder function after a complete spinal cord injury. Later the Finetech Brindley bladder control system is named academically as a sacral anterior root stimulator. It is an external, wireless device used to control the implant and its function.

Key Takeaways from the Sacral Nerve Stimulator Devices Market Report Study

Market size analysis for current sacral nerve stimulator devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the sacral nerve stimulator devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global sacral nerve stimulator devices market.

Various opportunities available for the other competitor in the sacral nerve stimulator devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current sacral nerve stimulator devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for sacral nerve stimulator devices market growth in the coming future?

Target Audience who can be benefited from this Sacral Nerve Stimulator Devices Market Report Study

Sacral nerve stimulator devices products providers

Research organizations and consulting companies

Sacral nerve stimulator device s-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in sacral nerve stimulator devices

Various End-users who want to know more about the sacral nerve stimulator devices market and the latest technological developments in the sacral nerve stimulator devices market.

Frequently Asked Questions for the Sacral Nerve Stimulator Devices Market:

1. What are sacral nerve stimulator devices?

The sacral nerve stimulator delivers gentle electrical impulses through a probe (a thin wire) that is placed near the sacral nerve thereby stimulating the bowel and bladder muscles to work normally.

2. What is the market for global sacral nerve stimulator devices?

The global sacral nerve stimulator devices market was valued at USD 1,064.05 million in 2023, growing at a CAGR of 11.66% during the forecast period from 2024 to 2030.

3. What are the drivers for global sacral nerve stimulator devices market?

The demand for sacral nerve stimulator devices is primarily being heightened by the increasing prevalence of overactive bladder, increasing cases of urge incontinence & fecal incontinence, the rising prevalence of prostate cancer, and others. In addition, the advancement in sacral nerve stimulator devices, and the increasing device launches and approvals among others are thereby contributing to the overall growth of the sacral nerve stimulator devices market during the forecast period from 2024-2030.

4. Who are the key players operating in the global sacral nerve stimulator devices market?

Some of the key market players operating in the sacral nerve stimulator devices market include Medtronic, Axonics, Inc., Boston Scientific Corporation, NeuroPace, Inc., Laborie, Biegler GmbH, Finetech Medical, and others.

5. Which region has the highest share in the sacral nerve stimulator devices market?

North America is expected to dominate the overall sacral nerve stimulator devices market during the forecast period from 2024-2030. Factors such as the rising prevalence of overactive bladder conditions (OAB) and urge incontinence, the increasing geriatric population, the growing demand for non-invasive treatment, and other factors aid in the growth of the sacral nerve stimulator market in North America. Furthermore, high disposable income, sophisticated healthcare infrastructure, and regulatory approval for new devices also helped the market growth in this region.

Table of Contents

1. Sacral Nerve Stimulator Device Market Report Introduction

2. Sacral Nerve Stimulator Device Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Sacral Nerve Stimulator Device Market Key Factors Analysis

• 4.1. Sacral Nerve Stimulator Device Market Drivers
  • 4.1.1. Increasing Prevalence of overactive bladder and fecal incontinence
  • 4.1.2. Increasing health issues in the geriatric population and increasing risk factors such as obesity, diabetes, hypertension
• 4.2. Sacral Nerve Stimulator Device Market Restraints and Challenges
  • 4.2.1. Side effects associated with the device
• 4.3. Sacral Nerve Stimulator Device Market Opportunities
  • 4.3.1. Rising research and development activity for wearable sacral nerve stimulator

5. Sacral Nerve Stimulator Device Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Sacral Nerve Stimulator Device Market

7. Sacral Nerve Stimulator Device Market Layout

• 7.1. By Product
  • 7.1.1. Implantable nerve stimulator
  • 7.1.2. External nerve stimulator
• 7.2. By Application
  • 7.2.1. Overactive bladder
  • 7.2.2. Urinary or bowel urge incontinence
  • 7.2.3. Non-obstructive urinary retention
  • 7.2.4. Chronic fecal incontinence
  • 7.2.5. Others
• 7.3. By End-User
  • 7.3.1. Hospitals
  • 7.3.2. Ambulatory Surgical Centers
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
    • 7.4.1.1. United States sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
    • 7.4.1.2. Canada Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
    • 7.4.1.3. Mexico Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
  • 7.4.2. Europe Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
    • 7.4.2.1. France Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
    • 7.4.2.2. Germany Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
    • 7.4.2.3. United Kingdom Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
    • 7.4.2.4. Italy sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
    • 7.4.2.5. Spain sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
    • 7.4.2.6. Rest of Europe sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
  • 7.4.3. Asia-Pacific Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
    • 7.4.3.1. China Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
    • 7.4.3.2. Japan Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
    • 7.4.3.3. India Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
    • 7.4.3.4. Australia Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
    • 7.4.3.5. South Korea Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
    • 7.4.3.6. Rest of Asia-Pacific Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
  • 7.4.4. Rest of the World (RoW) Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
    • 7.4.4.1. Middle East Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
    • 7.4.4.2. Africa Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
    • 7.4.4.3. South America Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)

8. Sacral Nerve Stimulator Device Market Company and Product Profiles

• 8.1. Medtronic
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Axonics, Inc.
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Boston Scientific Corporation
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4 .NeuroPace, Inc.
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Laborie.
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Biegler GmbH
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Finetech Medical
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us